ID   FHCR-1-2624/FH6/FHOT-1-3019
AC   CVCL_K275
SY   FH6
DR   CLO; CLO_0003240
DR   ATCC; HB-8873
DR   Wikidata; Q54834886
RX   Patent=US4904596;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8873.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_61093; Alpha-Neu5Ac-(2->3)-beta-D-Gal (1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer (Ganglioside B6).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
RX   Patent=US4904596;
RA   Hakomori, Sen-itiroh
RT   "Hybridoma antibody (FH6) defining a human cancer-associated
RT   difucoganglioside.";
RL   Patent number US4904596, 27-Feb-1990.
//